Utilizing Innovative Technology To Improve Compliance With Patient Elevation Guidelines – The Impact Of Angulus On Adherence To The Evidence-Based VAP-Prevention Bundle
Utilizing Innovative Technology To Improve Compliance With Patient Elevation Guidelines – The Impact Of Angulus On Adherence To The Evidence-Based VAP-Prevention Bundle
批准号:
9139729
负责人:
MICHELLE Ng GONG
金额:
$22.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-02 至 2019-04-30
关键词:
AdherenceAttentionBedsCenters for Disease Control and Prevention (U.S.)ClinicalComputer softwareContractsCost SavingsCritical CareCritical IllnessCross-Over StudiesCross-Over TrialsDataData AggregationData DisplayDevicesEffectivenessEvaluationEventFeedbackFocus GroupsFundingGoalsGrantGuidelinesHeadHospitalsImprove AccessIncidenceIntensive Care UnitsLengthMeasurementMeasuresMedicalMedical centerMethodsMissionMorbidity - disease rateNational Heart, Lung, and Blood InstituteNosocomial InfectionsNursesOutcomeOutpatientsPainPatient MonitoringPatient-Focused OutcomesPatientsPhasePositioning AttributePosturePractice GuidelinesPreventionProviderPublic HealthPublishingRandomizedScourgeSignal TransductionSiteStagingSternumSystemTechnologyTestingTimeTranslatingVentilatorWireless TechnologyWorkcommercializationcostdesigndigitalefficacy trialempoweredevidence baseexperiencehospital bedimprovedinnovative technologiesmortalitynovelproduct developmentprototypepublic health relevancesatisfactionsensorstandard of caretooltrendusabilityventilator-associated pneumonia
中文摘要
英文摘要
DESCRIPTION (provided by applicant): Each year in the U.S. over 250,000 ventilated patients in the intensive care unit contract Ventilator-associated pneumonia (VAP), a hospital-acquired infection which has captured the attention of numerous stakeholders in the critical care domain. VAP has a 30% mortality rate1,2 and results in an extended ICU stay of 4.3 days1,2,3,4, on average. Hospitals incur an additional $40,000 in incremental costs3 per patient, and a national average of Reducing the incidence of Ventilator-associated pneumonia (VAP) and $10 Billion is spent on VAP annually3,16. related ventilator-associated events (VAE) is of prime importance to clinicians, hospital stakeholders, accrediting agencies and ultimately patients. However, despite evidence that maintaining ventilated patients at an elevation between 30-45 degrees is correlated with significantly improved VAP outcomes3,6,10,12, there is currently a dearth of effective methods for accurately and efficiently measuring a patient's elevation in real time. Existing tools for measuring patient elevation are archaic, inflexible and unreliable. Without accurate, reliable and available data on a patient's elevation, evaluating and improving compliance with head of bed guidelines is challenging to say the least. A mechanism that accurately measures a patient's elevation and signals that information to nurses is highly desired, and can dramatically improve compliance with best-practice patient-elevation guidelines, which in turn would reduce the incidence of VAP, shorten ICU stays and translate into tremendous cost savings and improved clinical outcomes for hospitals. Angulus was developed to fill this gap in critical care technology. It is a novel sensor, which accurately measures patient elevation in real time - irrespective of a patient's idiosyncratic orientation - and transmits on-demand minute-to-minute data and aggregate trends to a corresponding display device via Bluetooth. Angulus is composed of two components - a wireless sensor which is affixed to the patient's sternum, and a corresponding software interface, which displays the patient elevation angle. Utilization of Angulus will empower critical care treatment teams to more efficiently monitor patients' elevation, and improve compliance to HOB guidelines. In this Phase I proposal we will collaborate with Albert Einstein/ Montefiore Medical center to: 1) conduct initil end-user focus groups, 2) validate the accuracy of Angulus as a patient elevation measurement tool, 3) implement a randomized cross over trial to measure the impact of Angulus on improving compliance with patient elevation guidelines, and 4) collect end-user satisfaction and usability scores and integrate critical functionality with an agile and iterative product development approach. By empowering critical care teams with intelligible, accessible and accurate on demand data about a patient's elevation angle in real time, Angulus will improve compliance with patient elevation guidelines. This work will have a tremendous impact on resolving a burdensome problem associated with increased patient morbidity and astronomical costs. This proposal is very highly aligned with the overall mission of NHLBI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TREAT ECARDS: Translating Evidence into Action: Electronic Clinical Decision Support in ARDS
-
批准号:9763432
-
项目类别:
-
资助金额:$39.79万
-
财政年份:2018
-
负责人:MICHELLE Ng GONG
-
依托单位:
Digital Implementation Intervention Trials in Acute Lung Care (DIGITAL-C) Network Planning
-
批准号:9756472
-
项目类别:
-
资助金额:$41.99万
-
财政年份:2018
-
负责人:MICHELLE Ng GONG
-
依托单位:
Einstein PETAL: Clinical Center for the PETAL Network
-
批准号:9172481
-
项目类别:
-
资助金额:$0.86万
-
财政年份:2014
-
负责人:MICHELLE Ng GONG
-
依托单位:
Einstein PETAL: Clinical Center for the PETAL Network
-
批准号:8704533
-
项目类别:
-
资助金额:$14.42万
-
财政年份:2014
-
负责人:MICHELLE Ng GONG
-
依托单位:
Einstein PETAL: Clinical Center for the PETAL Network
-
批准号:9062498
-
项目类别:
-
资助金额:$27.55万
-
财政年份:2014
-
负责人:MICHELLE Ng GONG
-
依托单位:
Early Insulin Therapy and Development of ARDS
-
批准号:7491770
-
项目类别:
-
资助金额:$45.4万
-
财政年份:2007
-
负责人:MICHELLE Ng GONG
-
依托单位:
Early Insulin Therapy and Development of ARDS
-
批准号:7866687
-
项目类别:
-
资助金额:$41.72万
-
财政年份:2007
-
负责人:MICHELLE Ng GONG
-
依托单位:
Early Insulin Therapy and Development of ARDS
-
批准号:7313911
-
项目类别:
-
资助金额:$48.92万
-
财政年份:2007
-
负责人:MICHELLE Ng GONG
-
依托单位:
Early Insulin Therapy and Development of ARDS
-
批准号:8057652
-
项目类别:
-
资助金额:$46.43万
-
财政年份:2007
-
负责人:MICHELLE Ng GONG
-
依托单位:
Surrogate Consent in Research
-
批准号:7868027
-
项目类别:
-
资助金额:$40.3万
-
财政年份:2006
-
负责人:MICHELLE Ng GONG
-
依托单位:
Surrogate Consent in Research
-
批准号:7442282
-
项目类别:
-
资助金额:$41.15万
-
财政年份:2006
-
负责人:MICHELLE Ng GONG
-
依托单位:
Surrogate Consent in Research
-
批准号:7074494
-
项目类别:
-
资助金额:$41.96万
-
财政年份:2006
-
负责人:MICHELLE Ng GONG
-
依托单位:
Surrogate Consent in Research
-
批准号:7997343
-
项目类别:
-
资助金额:$41.15万
-
财政年份:2006
-
负责人:MICHELLE Ng GONG
-
依托单位:
Surrogate Consent in Research
-
批准号:7272029
-
项目类别:
-
资助金额:$41.15万
-
财政年份:2006
-
负责人:MICHELLE Ng GONG
-
依托单位:
Molecular Epidemiology of ARDS and Septic Shock
-
批准号:6537979
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2001
-
负责人:MICHELLE Ng GONG
-
依托单位:
Molecular Epidemiology of ARDS and Septic Shock
-
批准号:6756398
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2001
-
负责人:MICHELLE Ng GONG
-
依托单位:
Molecular Epidemiology of ARDS and Septic Shock
-
批准号:6607545
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2001
-
负责人:MICHELLE Ng GONG
-
依托单位:
Molecular Epidemiology of ARDS and Septic Shock
-
批准号:6322056
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2001
-
负责人:MICHELLE Ng GONG
-
依托单位:
Molecular Epidemiology of ARDS and Septic Shock
-
批准号:6898701
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2001
-
负责人:MICHELLE Ng GONG
-
依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈立达
-
依托单位: